Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

EnWave Signs Agency Agreement with CD Process LLC


EnWave Signs Agency Agreement with CD Process LLC

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 11/05/13 -- EnWave Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) ("EnWave", or the "Company") announced today that it has signed an Agency Agreement (the "Agreement") with CD Process LLC ("CD"), a North American-based technology company that addresses the ingredient processing requirements of the global food industry. This Agreement broadens EnWave's sales network for Radiant Energy Vacuum ("REV(TM)") technology by partnering with a business entity comprised of several food industry veterans that have extensive technology, research & development and sales & marketing expertise. Furthermore, due to a very close working relationship with EnWave, CD's key personnel have a high level of experience and proficiency working with REV(TM) technology.

CD will actively pursue commercial opportunities for REV(TM) technology by utilizing their existing network of food industry contacts. They also have access to nutraREV(R) technology to conduct product development work for a number of potential clients throughout the United States of America. The end goal of CD is to eventually establish a centralized toll processing facility, including licensed REV(TM) technology for specific applications, to service a number of clients in the food and nutraceutical industries. All other details of the Agreement are confidential.

"The management of CD Process is extremely qualified to work as an extension of our business development efforts," stated Dr. Tim Durance, Chairman and Co-CEO of EnWave. "It is EnWave's immediate goal to significantly increase its agent and sales network in order to increase the commercialization of REV(TM) technology in several established market sectors including meat, cheese, fruit, vegetables, enzymes and spice product areas."

About CD Process LLC

Based in the Midwest of the United States of America, CD Process is a food processing company set up to serve the ingredient processing requirements of the food industry. With their proprietary technologies they can dehydrate and, if required, can particle size reduce food ingredients whilst retaining a high nutritional content within the ingredients. This is achieved because they can dehydrate at lower temperatures than conventional methods. Their technologies can also produce unique textures not possible through traditional methods. For more information on CD Process please visit www.cdprocess.com.

About EnWave

EnWave Corporation is a Vancouver-based industrial technology company developing commercial applications for its proprietary Radiant Energy Vacuum (REV(TM)) dehydration technology. In June 2013, Hormel Foods Corporation signed a royalty-bearing commercial license to use REV(TM) technology for the production of a number of products. Recently, EnWave formed a Limited Liability Partnership with Lucid Capital Management to develop, manufacture, market and sell all-natural cheese snack products in the United States. Also, the Company has licensed REV(TM) technology to a leading North American enzyme company to begin dehydrating a series of food-related enzymes for their Tier 1 customers. Lastly, the company licensed REV(TM) technology to Milne Fruit Products Inc in 2011, its first major U.S. customer, to support a launch of healthy berry snacks and powders across most major markets in North America. EnWave has entered into a wide range of research and collaboration agreements with an expanding list of multinational companies, including Nestle, Kellogg's, Grupo Bimbo, Grimmway Farms, Ocean Spray Cranberries, Bonduelle, Cherry Central, Sun-Maid Growers, Gay Lea Foods and Merck. EnWave is introducing REV(TM) as a new dehydration standard in the food and biological material sectors: potentially faster and cheaper than freeze drying, with better end product quality than air drying or spray drying.

EnWave currently has six REV(TM) platforms: commercial-scale nutraREV(R) and MIVAP(R) are used in the food industry to dry fruits, vegetables, meat, herbs and seafood quickly and at low-cost, while maintaining high levels of nutrition, taste, texture and colour. The Company is also developing powderREV(TM) for bulk dehydration of food cultures, probiotics and fine biochemicals such as enzymes; quantaREV(TM) for continuous, high-volume low-temperature drying of pastes, gels, liquids, or particulates; and bioREV(TM) and freezeREV(TM) as new methods to stabilize and dehydrate biopharmaceuticals such as vaccines and antibodies. More information about EnWave is available at www.enwave.net.

EnWave Corporation

Dr. Tim Durance, Chairman & Co-CEO

Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures, and the expected synergies following the closing are forward-looking statements. All third party references to market information in this release are not guaranteed to be accurate as the Company did not conduct the original primary research. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Contacts: EnWave Corporation Mr. John McNicol President & Co-CEO (604) 601-8524 john.mcnicol@enwave.net

EnWave Corporation Mr. Brent Charleton Vice President, Corporate Affairs (778) 378-9616 bcharleton@enwave.net www.enwave.net

Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement